As PHGDH is the rate-limiting enzyme of serine synthesis, this finding implies substantial cell-to-cell variability in the level of de novo serine biosynthesis from the glycolytic intermediate, 3-phosphoglycerate (3PG) (Fig. 1A) in each cancer cell line when grown in complete growth medium. Here, PHGDH is linked to cancer.